Some results suggest that altered expression of TfR1/CD71 may be used as a marker helpful in distinguishing papillary thyroid carcinoma from papillary hyperplasia and follicular variant from benign follicular-patterned lesions. This evidence concerns the gene TFRC and differentiated thyroid carcinoma.